PDI Launches New Advanced Skin Antisepsis Platform
PDI announces the launch of its new Advanced Skin Antisepsis platform, PDI Prevantics. Under this platform, the company is investing in innovations that provide the most efficient and advanced evidence-based solutions for preventing healthcare associated infections. These innovations will include new formulations, applications and delivery systems.
The introduction of the new PDI Prevantics brand positions us toward developing a platform that supports a broader range of advanced skin antisepsis solutions and builds on our commitment to empower healthcare professionals to Be the Difference in reducing infections and controlling associated costs, says Dan Marsh, executive vice president for PDI.Â
The PDI Prevantics platform will house both future and current advanced skin antiseptics, starting with the existing Chlorascrub line. As the first pre-operative and pre-injection skin antiseptic with a 3.15 percent chlorhexidine gluconate (CHG) and 70 percent isopropyl alcohol, Chlorascrub has proven to improve outcomes and reduce healthcare costs, making it a perfect fit for the new PDI Prevantics platform. Product packaging reflecting the new name will transition in the market late January through early February. The formulation, delivery format and ordering procedures for the product will remain the same.
Â
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.
